|
⚲
|
| Xanodyne Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001335480 |
| Sale | 2009-05-15 ($87.8 M Offered, $87.8 M Sold) |
| Fund | |
| Phone | 8593717581 |
| Address | One Riverfront Place Newport, 41071 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Activant RN Holdings, LP
✚
|
0.0 | |
|
Workweek Fund I LP
✚
|
0.0 | |
|
WorkWell Fund I LLC
✚
|
0.0 | |
|
Activate Healthcare, LLC
✚
|
0.0 | |
|
Best Alliance Worldwide Investments Ltd
✚
|
0.0 | |
|
Beta Boom Fund II, LP
✚
|
0.0 | |
|
Beta Fund LLC
✚
|
0.0 | |
|
Betaworks Effervescence, LLC
✚
|
0.0 | |
|
BetDex Labs, Inc.
✚
|
0.0 | |
|
Worksteady, Inc.
✚
|
0.0 |